Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha Lipoic Acid for Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer
NCT05023863Phase 3Unknown
- Sponsor
- Ain Shams University
- Start
- Sep 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of alpha-lipoic acid in oral mucositis (OM) (2 arms), sponsored by Ain Shams University. Primary endpoint: Incidence and severity of radiation induced oral mucositis at 4 months. Status: unknown.
02
Drugs
alpha-lipoic acid
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT05023863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05023863.